Therapeutic peptides
US10793633B2 · kind B2 · utility
1Cited by
44References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 15, 2016 |
| Grant date | Oct 6, 2020 |
| Priority date | — |
| Expiry date | Nov 25, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides, in part, compositions comprising peptides that immunospecifically bind to a defined binding partner, such as MHC class I polypeptide-related sequence A (MICA), or an epitope thereon. In some embodiments, the peptides comprise one or more complementarity determining regions relating to the complementarity regions shown in Table 1. The disclosure also provides methods of treating cancer in a subject using the compositions disclosed herein, and methods of isolating human antibodies from cancer patients following immunotherapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.